Virtus Health Specialist Diagnostics

Site

Melbourne Laboratory

Accreditation No.

19906

Site No.

18681

Date of Accreditation

05 May 2010

Address

Ground and 2nd Floors, 344 Victoria Parade
East Melbourne, VIC 3002
Australia

mivf.com.au

Contact

Mrs Josephine Ritchie P: +61 (03) 94734571

Availability

Services available to external clients

Supervision

GX (General)

Scope of Accreditation

Melbourne Laboratory

ISO 15189 (2012)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Medicare expiry date

17 Jul 2024

Last Activity Date

13 Dec 2021

Service Product Determinant
Chemical pathology - Detection and/or quantitation of tumour markers Serum CA125 antigen (CA125)
Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) Serum Dehydroepiandrosterone sulfate (DHEAS); Sex hormone binding globulin (SHBG); Testosterone
Anti-Mullerian hormone (AMH)
Chemical pathology - Diagnosis and management of diabetes mellitus Blood Glycated haemoglobin (HbA1c)
Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia Serum HDL - Quantitation
Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies Serum Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Total; Chloride; Cholesterol - Total; Creatine kinase; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urea; Uric acid; γ-Glutamyltransferase
Chemical pathology - Investigation for folate deficiency Serum Folate
Chemical pathology - Iron studies Serum Ferritin; Iron; Transferrin
Chemical pathology - Quantitation of vitamins Serum Vitamin D
Cobalamin (vitamin B12)
Chemical pathology - Tests for thyroid function Serum Thyroxine (T4) - Free
Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalities Blastomere; Blood; Cells from embryo biopsy; Other body fluids; Products of conception (POC); Tissues; Trophectoderm Aneuploidy detection for chromosomes; Chromosomal rearrangement; Cytogenetic analysis and reporting; Karyomapping for known single gene disorders; Pathogenic copy number changes
Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy Serum Human chorionic gonadotropin (hCG) - Quantitative total
Infertility and pregnancy tests including assisted reproductive technology - Infertility (including in-vitro fertilisation) related endocrinology Serum Follicle stimulating hormone (FSH); Luteinising hormone (LH); Oestradiol; Progesterone; Prolactin; Thyroid stimulating hormone (TSH)
Infertility and pregnancy tests including assisted reproductive technology - Investigation of sperm Semen Sperm antibodies
Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy) Semen Vitality
Morphology; Motility
Leucocytes (white blood cells, WBC); pH
Volume
Sperm number
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes Blastomere; Blood; Buccal swabs; Cells from embryo biopsy; Fluids; Products of conception (POC); Tissues; Trophectoderm Mitochondrial disorders - Mito, MELAS, MERRF, mtDNA, POLG, Alpers, Leigh disease (LHON), NARP, Kearns-Sayre, MIRAS, CPEO; Rare autosomal dominant single gene disorders; Rare autosomal recessive single gene disorders; Rare x-linked single gene disorders; Variants in the nuclear genome
Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted panels for inherited (germline) DNA/RNA changes Blastomere; Blood; Buccal swabs; Cells from embryo biopsy; Products of conception (POC); Trophectoderm Aneuploidy screening; Variants in the nuclear genome
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes Blastomere; Cells from embryo biopsy; Products of conception (POC); Trophectoderm Aneuploidy screening; Chromosomal rearrangement; Variants in the nuclear genome
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted panels for inherited (germline) DNA/RNA changes Blastomere; Cells from embryo biopsy; Products of conception (POC); Trophectoderm Aneuploidy screening; Chromosomal rearrangement; Variants in the nuclear genome
Molecular genetics - Pre-implantation genetic testing Biopsied embryonic cell(s) - Blastomere/trophectoderm; Blastomere; Blood; Cells from embryo biopsy; Trophectoderm; Whole blood Aneuploidy screening of amplified trophectoderm/blastomere DNA; Chromosome copy number analysis; Karyomapping for known single gene disorders
Molecular genetics - Predictive genetic testing - Targeted genes Blastomere; Cells from embryo biopsy; Products of conception (POC); Trophectoderm Aneuploidy screening; Chromosomal rearrangement; Variants in the nuclear genome
Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes Blastomere; Cells from embryo biopsy; Products of conception (POC); Trophectoderm Aneuploidy screening; Chromosomal rearrangement; Variants in the nuclear genome

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.